Humacyte (HUMA) News Today $4.08 -0.19 (-4.45%) (As of 12/12/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Humacyte, Inc. (HUMA)December 12 at 12:56 PM | globenewswire.comHumacyte's (HUMA) Statements to Investors Called Into Question in Light of FDA Violations – Hagens BermanDecember 12 at 12:04 PM | globenewswire.comFaruqi & Faruqi Reminds Humacyte Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 17, 2025 - HUMADecember 12 at 11:03 AM | prnewswire.comClass Action Filed Against Humacyte, Inc. (HUMA) - January 17, 2025 Deadline to Join - Contact The Gross Law FirmDecember 12 at 5:45 AM | prnewswire.comHUMA Investors Have Opportunity to Lead Humacyte, Inc. Securities Fraud LawsuitDecember 11 at 7:21 PM | prnewswire.comInvestors in Humacyte, Inc. Should Contact Levi & Korsinsky Before January 17, 2025 to Discuss Your Rights – HUMADecember 11 at 1:00 PM | globenewswire.comHUMA Investors Have Opportunity to Lead Humacyte, Inc. Securities Fraud Lawsuit with the Schall Law FirmDecember 11 at 10:41 AM | prnewswire.comHUMACYTE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Humacyte, Inc. and Encourages Investors to Contact the FirmDecember 10 at 9:00 PM | globenewswire.comHUMA Stockholders with Large Losses Should Contact Shareholder Rights Law Firm Robbins LLP for Information About the Humacyte, Inc. Class ActionDecember 10 at 4:56 PM | prnewswire.comROSEN, A LEADING LAW FIRM, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUMADecember 10 at 4:28 PM | globenewswire.comLost Money on Humacyte, Inc.(HUMA)? Join Class Action Suit Seeking Recovery – Contact The Gross Law FirmDecember 10 at 12:42 PM | globenewswire.comJanuary 17, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against HUMADecember 10 at 6:08 AM | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Humacyte, Inc. of Class Action Lawsuit and Upcoming Deadlines - HUMADecember 9 at 9:44 PM | prnewswire.comHumacyte's (HUMA) Statements to Investors Called Into Question in Light of FDA Violations – Hagens BermanDecember 9 at 1:32 PM | globenewswire.comThe Gross Law Firm Reminds Humacyte, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 17, 2025 - HUMADecember 9 at 5:45 AM | prnewswire.comHUMA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Humacyte, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitDecember 8, 2024 | globenewswire.comROSEN, SKILLED INVESTOR COUNSEL, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUMADecember 7, 2024 | markets.businessinsider.comHUMA Investors Have Opportunity to Lead Humacyte, Inc. Securities Fraud LawsuitDecember 6, 2024 | prnewswire.comHumacyte (NASDAQ:HUMA) Trading Up 9.1% - Should You Buy?Humacyte (NASDAQ:HUMA) Shares Up 9.1% - Here's What HappenedDecember 6, 2024 | marketbeat.comROSEN, LEADING INVESTOR COUNSEL, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUMADecember 6, 2024 | globenewswire.comLevi & Korsinsky Reminds Humacyte, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 17, 2025 - HUMADecember 6, 2024 | prnewswire.comHUMACYTE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Humacyte, Inc. and Encourages Investors to Contact the FirmDecember 5, 2024 | globenewswire.comHUMA Investors Have Opportunity to Lead Humacyte, Inc. Securities Fraud LawsuitDecember 5, 2024 | gurufocus.comLevi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of January 17, 2025 in Humacyte, Inc. Lawsuit – HUMADecember 5, 2024 | globenewswire.comHUMA Investors Have Opportunity to Lead Humacyte, Inc. Securities Fraud LawsuitDecember 5, 2024 | prnewswire.comHumacyte's (HUMA) Statements to Investors Called Into Question in Light of FDA Violations – Hagens BermanDecember 5, 2024 | globenewswire.comSHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of HumacyteDecember 5, 2024 | prnewswire.comShareholder Alert for Humacyte, Inc. (NASDAQ:HUMA)December 5, 2024 | tipranks.comHumacyte, Inc. (NASDAQ:HUMA) Director Michael T. Constantino Buys 4,600 SharesDecember 5, 2024 | insidertrades.comThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of January 17, 2025 in Humacyte, Inc. Lawsuit - HUMADecember 5, 2024 | prnewswire.comThe Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Humacyte, Inc. (HUMA) ShareholdersDecember 4, 2024 | globenewswire.comThrivent Financial for Lutherans Acquires New Shares in Humacyte, Inc. (NASDAQ:HUMA)Thrivent Financial for Lutherans bought a new position in shares of Humacyte, Inc. (NASDAQ:HUMA - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 130,894 shares of the company's stockDecember 4, 2024 | marketbeat.comROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUMADecember 3, 2024 | globenewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Humacyte, Inc.- HUMADecember 3, 2024 | prnewswire.comHumacyte, Inc. Is Being Sued For For Violating Securities Regulations And Investors With Losses Are Invited To Help The Schall Law FirmDecember 3, 2024 | markets.businessinsider.comGlancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Humacyte, Inc. (HUMA)December 3, 2024 | globenewswire.comSHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of HumacyteDecember 3, 2024 | globenewswire.comHumacyte, Inc. Class Action Lawsuit Alert: Johnson Fistel Announces Shareholders with Losses Should Contact the Law Firm for More InformationDecember 3, 2024 | globenewswire.comHumacyte, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky ...December 3, 2024 | gurufocus.comHumacyte, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before January 17, 2025 to Discuss Your Rights - HUMADecember 3, 2024 | prnewswire.comRobbins LLP Urges HUMA Stockholders with Large Losses to Contact the Firm for Information About the Humacyte, Inc. Class Action LawsuitDecember 3, 2024 | globenewswire.comKirby McInerney LLP Reminds Humacyte (HUMA) Investors of Class Action Filing and Encourages Investors to Contact the FirmDecember 2, 2024 | businesswire.comHUMA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Humacyte, Inc. ...December 2, 2024 | gurufocus.comHUMA Investors Have Opportunity to Lead Humacyte, Inc. Securities Fraud LawsuitDecember 2, 2024 | gurufocus.comHUMA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Humacyte, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitDecember 2, 2024 | globenewswire.comHUMA Investors Have Opportunity to Lead Humacyte, Inc. Securities Fraud LawsuitDecember 2, 2024 | prnewswire.comHumacyte's (HUMA) Statements to Investors Called Into Question in Light of FDA Violations – Hagens BermanDecember 2, 2024 | globenewswire.comHUMACYTE, INC. (NASDAQ: HUMA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Humacyte, Inc. ...December 2, 2024 | gurufocus.comHumacyte to Present at the Piper Sandler 36th Annual Healthcare ConferenceDecember 2, 2024 | globenewswire.comShareholders of Humacyte, Inc. Should Contact Levi & Korsinsky Before January 17, 2025 to ...December 2, 2024 | gurufocus.com Get Humacyte News Delivered to You Automatically Sign up to receive the latest news and ratings for HUMA and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now HUMA Media Mentions By Week HUMA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HUMA News Sentiment▼0.080.79▲Average Medical News Sentiment HUMA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HUMA Articles This Week▼236▲HUMA Articles Average Week Get Humacyte News Delivered to You Automatically Sign up to receive the latest news and ratings for HUMA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AKRO News Today AMPH News Today MIRM News Today IRON News Today TARS News Today HRMY News Today GLPG News Today XNCR News Today ARVN News Today NAMS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HUMA) was last updated on 12/12/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredThis could bring inflation roaring back (I’m concerned)"For AI... We have to produce massive electricity that we don't have. Nuclear has become very safe, very good....The Oxford Club | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredCaught on camera (shocking new AI tech)Everyone is talking about the “Magnificent Seven"... Nvidia, Meta, Google, Microsoft, etc. Meanwhile, they ...Banyan Hill Publishing | SponsoredThis happened before the 1987 crash too…I’d urge you to watch my latest exposé into what’s really going on in the tech sector… why I believe we could ...Porter & Company | SponsoredPrepare Now Before This Looming $2 Trillion D.C. ShockMillions of traders could get blindsided by this election-year shock on December 18th… And if you do nothin...Timothy Sykes | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Humacyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Humacyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HUMA Stock Alerts